Skip to content

The effect of combined lidocaine and dexmedetomidine nebulized inhalation on hemodynamics and stress response during general anesthesia tracheal intubation.

The effect of Lidocaine combined with Dexmedetomidinenebulized nebulized inhalation on hemodynamics and stress response during general anesthesia tracheal intubation.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085809
Enrollment
Unknown
Registered
2024-06-19
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with general anesthesia tracheal intubation

Interventions

Group L (Lidocaine Group): 2% Lidocaine inhalation nebulization group,: 2% Lidocaine inhalation nebulization
Group D (Dexmedetomidine Group): Dexmedetomidine inhalation nebulization group,:Dexmedetomidine inhalation nebulization
Group LD (Lidocaine-Dexmedetomidine Group): Lidocaine combined with Dexmedetomidine inhalation nebulization group.:Lidocaine combined with Dexmedetomidine inhalation nebulization

Sponsors

Department of Anesthesiology, Huizhou Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ?Patients undergoing laparoscopic cholecystectomy surgery with an American Society of Anesthesiologists (ASA) physical status classification of I to II;?Age between 18 to 65 years old;?No anticipated difficulty with intubation based on preoperative assessment, and good visibility of the laryngeal structures during intubation (Cormack-Lehane grading I to II);?Patients undergoing orotracheal intubation under general anesthesia and have obtained written consent from the patient and their family;?Good patient compliance and ability to cooperate with the relevant examinatio

Exclusion criteria

Exclusion criteria: ?Blood pressure =180/110 mmHg in a calm state upon entering the room;?Diseases such as pulmonary infection, bradycardia, conduction block, arrhythmia, and abnormalities in liver and kidney function;?Difficulty in verbal communication;?Allergies to all relevant medications;?Predicted difficult airway;?History of dependence on alcohol, sedatives, analgesics, etc.;?Body Mass Index (BMI) > 30 kg/m^2, etc.

Design outcomes

Primary

MeasureTime frame
Blood Pressure:systolic blood pressure (SBP), diastolic blood pressure (DBP);Heart Rate(HR);Pulse Oximetry (SPO2);Serum Levels of Blood Glucose (Glu);Cortisol (COR);Airway Peak Pressure/The Peak Airway Pressure (Ppeak);Airway Plateau Pressure/The Plateau Airway Pressure(Pplat);Airway Resistance(Raw);Pulmonary Dynamic Compliance (Cdyn) ;

Secondary

MeasureTime frame
Preoperative sedation score;Anesthesia onset time;Dosage of general anesthesia;The occurrence of cardiovascular adverse reactions during induction;

Countries

china

Contacts

Public ContactZhou Wendan

Huizhou Sixth People's Hospital

704440317@qq.com+86 157 6824 8225

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026